朱雀三号中大型可重复使用运载火箭
Search documents
冲刺商业航天第一股!蓝箭航天IPO获受理:拟募资75亿,需实现可复用火箭发射载荷成功入轨
Sou Hu Cai Jing· 2026-01-01 00:07
Core Viewpoint - Blue Arrow Aerospace Technology Co., Ltd. is set to launch its IPO on the Sci-Tech Innovation Board, aiming to raise 7.5 billion yuan to enhance its capabilities in reusable rocket technology and production capacity [1][2]. Company Overview - Blue Arrow Aerospace, founded in 2015 and headquartered in Beijing, focuses on the research, production, and commercial launch services of liquid oxygen-methane engines and rockets [8]. - The company aims to build a comprehensive aerospace technology ecosystem centered around medium to large reusable liquid oxygen-methane rockets [9]. IPO Details - The IPO application was accepted on December 31, 2025, with a fundraising target of 7.5 billion yuan [1][2]. - The underwriting institution for the IPO is China International Capital Corporation [2]. Financial Performance - Revenue figures from 2022 to the first half of 2025 are as follows: 780,000 yuan, 3.95 million yuan, 4.27 million yuan, and 36.43 million yuan, respectively [3]. - The net losses for the same period were 800 million yuan, 1.188 billion yuan, 876 million yuan, and 597 million yuan [3]. - The company has a high R&D investment relative to revenue, with ratios of 62231.80%, 21012.51%, 14318.09%, and 987.01% for the respective years [5]. Debt and Equity Structure - As of June 30, 2025, the company reported a consolidated and parent company undistributed profit of -4.84 billion yuan and -3.22 billion yuan, respectively [5]. - The controlling shareholder, Zhang Changwu, holds 6.7277% of the shares directly and controls a total of 75.2019% of the voting rights through various partnerships [6]. Industry Context - The commercial aerospace industry in China has reached a scale of 2.5 trillion to 2.8 trillion yuan, with an annual compound growth rate exceeding 20% [11]. - The global commercial aerospace market is valued between 624 billion to 700 billion USD, reflecting a year-on-year growth of 22% [10].